|
YARS2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.715000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.381400E-01 |
| Normal-vs-Stage2 |
4.363600E-01 |
| Normal-vs-Stage3 |
5.827600E-01 |
| Normal-vs-Stage4 |
8.550800E-01 |
| Stage1-vs-Stage2 |
7.481000E-01 |
| Stage1-vs-Stage3 |
1.047430E-01 |
| Stage1-vs-Stage4 |
3.504000E-01 |
| Stage2-vs-Stage3 |
2.702400E-01 |
| Stage2-vs-Stage4 |
3.876200E-01 |
| Stage3-vs-Stage4 |
7.668600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.025000E-01 |
| Normal-vs-AfricanAmerican |
7.083600E-01 |
| Normal-vs-Asian |
5.104800E-01 |
| Caucasian-vs-AfricanAmerican |
9.421000E-01 |
| Caucasian-vs-Asian |
8.673200E-01 |
| AfricanAmerican-vs-Asian |
8.616800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.439200E-01 |
| Normal-vs-Female |
6.977000E-01 |
| Male-vs-Female |
5.656000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.921200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.169800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.063800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.667200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.664400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.346200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.536600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.052800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.998200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.015400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.113600E-01 |
| Classical-VS-Follicular |
2.188000E-02 |
| Classical-VS-Other |
7.643600E-01 |
| Classical-VS-Normal |
1.584210E-01 |
| Tall-VS-Follicular |
4.782800E-01 |
| Tall-VS-Other |
5.542600E-01 |
| Tall-VS-Normal |
9.379200E-01 |
| Follicular-VS-Other |
3.436800E-01 |
| Follicular-VS-Normal |
3.488800E-01 |
| Other-VS-Normal |
5.854600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.673400E-01 |
| Normal-vs-N1 |
8.863600E-01 |
| N0-vs-N1 |
7.830400E-01 |
|
|
